NSPR (InspireMD) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


NSPR InspireMD Inc NSPR
35 GF Score
Price $0.70
GF Value $1.78
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is InspireMD Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

InspireMD's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

NSPR vs TELA, MYO, PAVM: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Devices subindustry, InspireMD's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InspireMD Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where InspireMD's Margin of Safety % (DCF FCF Based) falls into.


NSPR
35GF Score
InspireMD Inc NSPR
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is InspireMD (NSPR) Overvalued in 2026?

Based on GuruFocus' analysis, InspireMD stock appears to be undervalued. The current stock price of $0.70 is trading 60.7% below its estimated GF Value™ of $1.78. GuruFocus considers InspireMD to be Possible Value Trap.

Key valuation signals for NSPR:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $1.78 vs. price of $0.70 (60.7% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the NSPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InspireMD Business Description

Other Exchanges II2:Germany
Address 6303 Waterford District Drive, Suite 215, Miami, FL, USA, 33126
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
35GF Score

Get the complete analysis for NSPR

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.70
Price
$1.78
GF Value